80 results  1 of 5 

1 Differential Expression of NME4 in Trophoblast Stem-Like Cells and Peripheral Blood Mononuclear Cells of Normal Pregnancy and Preeclampsia
Ji Hea Yu, Yun Ji Jung, Myung-Sun Kim, Sung-Rae Cho, Young-Han Kim
J Korean Med Sci.2023;38(16):e128.  Published online 2023 April 6     DOI: http://dx.doi.org/10.3346/jkms.2023.38.e128
      
2 Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
Shun Kawashima, Kole Joachim, Maen Abdelrahim, Ala Abudayyeh, Kenar D. Jhaveri, Naoka Murakami
Korean J Transplant.2022;36(2):82-98.   Published online 2022 June 3     DOI: http://dx.doi.org/10.4285/kjt.22.0013
      
3 Evaluation of the effects of disulfiram, an alcohol-aversive agent with anti-cancer activity, on mouse bone marrow cells
Seo-Ro Park, Hong-Gu Joo
Korean J Physiol Pharmacol.2022;26(3):157-164.   Published online 2022 May 1     DOI: http://dx.doi.org/10.4196/kjpp.2022.26.3.157
      
4 Glasgow prognostic score and combined positive score for locally advanced rectal cancer
Yanru Feng, Jialin Luo, Peng Liu, Luying Liu, Yuan Zhu, Guoping Cheng, Linfeng Zheng
Ann Surg Treat Res.2022;102(3):153-158.   Published online 2022 March 4     DOI: http://dx.doi.org/10.4174/astr.2022.102.3.153
      
5 Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.2022;54(2):458-468.   Published online 2021 September 10     DOI: http://dx.doi.org/10.4143/crt.2021.425
      
6 An update on immunotherapy with PD-1 and PD-L1 blockade
Sung Ae Koh
Yeungnam Univ J Med.2021;38(4):308-317.   Published online 2021 September 9     DOI: http://dx.doi.org/10.12701/yujm.2021.01312
      
7 Apoptin gene delivery by a PAMAM dendrimer modified with a nuclear localization signal peptide as a gene carrier for brain cancer therapy
Yoonhee Bae, Jell Lee, Changwon Kho, Joon Sig Choi, Jin Han
Korean J Physiol Pharmacol.2021;25(5):467-478.   Published online 2021 September 1     DOI: http://dx.doi.org/10.4196/kjpp.2021.25.5.467
      
8 Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab.2021;36(3):599-606.   Published online 2021 June 2     DOI: http://dx.doi.org/10.3803/EnM.2021.965
      
9 Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma
Min Young Lee, Chan-Jeoung Park, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, Eul Ju Seo, Jung-Hee Lee, Dok Hyun Yoon, Cheolwon Suh
Ann Lab Med.2021;41(3):259-267.   Published online 2021 May 1     DOI: http://dx.doi.org/10.3343/alm.2021.41.3.259
      
10 Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Kyu Sang Lee, Gheeyoung Choe
J Pathol Transl Med.2021;55(3):163-170.   Published online 2021 April 7     DOI: http://dx.doi.org/10.4132/jptm.2021.02.22
      
11 Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab.2021;36(2):413-423.   Published online 2021 April 6     DOI: http://dx.doi.org/10.3803/EnM.2020.906
      
12 Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
Min Ho Lee, Kyung-Rae Cho, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jung-Il Lee
J Korean Neurosurg Soc.2021;64(2):271-281.   Published online 2020 December 4     DOI: http://dx.doi.org/10.3340/jkns.2020.0135
      
13 Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9.  Published online 2020 February 17     DOI: http://dx.doi.org/10.4110/in.2020.20.e9
      
14 Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8.  Published online 2020 February 10     DOI: http://dx.doi.org/10.4110/in.2020.20.e8
      
15 Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immune Netw.2020;20(1):e10.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e10
      
16 Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e8
      
17 Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e9
      
18 Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immune Netw.2020;20(1):e10.  Published online 2020 January 27     DOI: http://dx.doi.org/10.4110/in.2020.20.e10
      
19 Fluoxetine Induces Apoptotic and Oxidative Neuronal Death Associated with The Influx of Copper Ions in Cultured Neuronal Cells
Shinae Hwang, Jong-Keun Kim
Chonnam Med J.2020;56(1):20-26.   Published online 2020 January 22     DOI: http://dx.doi.org/10.4068/cmj.2020.56.1.20
      
20 PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
Cancer Res Treat.2020;52(3):661-670.   Published online 2020 January 10     DOI: http://dx.doi.org/10.4143/crt.2019.718
      

 1 of 5